Thank Melua, that was my understanding but this didn't seem to match up with HG's quote
"If this zone (the first of success) just produces at the intial result then thats $US2M in gross revenue a year. Assuming the other 5 zones do no more than match that then thats $US12M all up for VIL. Lets say a net cashflow of $US11M just for arguments sakes."
And thanks HG, I'm not kikcing the mc,
but thought its worth mentioning since you had a quote from an "expert" of "your on a winner I reckon" which can be quite emotive for people.
The well may be a winner but it and all the other assets & prospects should be considered against the mc imo, since you were talking about fundamentals. Charting is different but not the topic of you post.
Gotta go out to dinner now with our newborn, again all the best folks :)
- Forums
- ASX - By Stock
- VIL
- it was time to speak to an expert
it was time to speak to an expert, page-38
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VIL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online